It's interesting currently the latest immunotherapies for Melanoma are far more expensive than SIRT to give PFS 11 months compared to what we are getting with in mCRC - 7.9 months. $1M compared to the cost of spheres $20-40K (single or bi-lobar therapy)- talking about the medication only, not other costs like staff, hospital stay etc. OF course these are different tumours etc. http://www.medscape.com/viewarticle/845707?src=wnl_edit_cfna&uac=164506DK The article says clearly prices have to move (i.e. they are unaffordable).
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
